Vertex Pharmaceuticals and Enlaza Therapeutics formed a strategic collaboration to develop new drug conjugates using Enlaza's War-Lock platform.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vertex Pharmaceuticals and Enlaza Therapeutics formed a strategic collaboration to develop new drug conjugates using Enlaza's War-Lock platform.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Vertex Pharmaceuticals
American pharmaceutical company
Coverage
Newest first; wire copies grouped- Business WireEnlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases LA